Aspiriant LLC’s Danaher DHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $774K | Sell |
4,080
-415
| -9% | -$88.4K | 0.02% | 176 |
|
|
2025
Q4 | $1.03M | Buy |
4,495
+366
| +9% | +$80.5K | 0.03% | 156 |
|
|
2025
Q3 | $819K | Sell |
4,129
-465
| -10% | -$92.5K | 0.03% | 164 |
|
|
2025
Q2 | $908K | Sell |
4,594
-216
| -4% | -$41.9K | 0.03% | 155 |
|
|
2025
Q1 | $986K | Sell |
4,810
-86
| -2% | -$18.8K | 0.03% | 141 |
|
|
2024
Q4 | $1.12M | Sell |
4,896
-618
| -11% | -$152K | 0.04% | 133 |
|
|
2024
Q3 | $1.53M | Sell |
5,514
-56
| -1% | -$14.8K | 0.06% | 110 |
|
|
2024
Q2 | $1.39M | Sell |
5,570
-956
| -15% | -$242K | 0.06% | 110 |
|
|
2024
Q1 | $1.63M | Sell |
6,526
-62
| -0.9% | -$15.1K | 0.07% | 109 |
|
|
2023
Q4 | $1.52M | Sell |
6,588
-813
| -11% | -$173K | 0.07% | 108 |
|
|
2023
Q3 | $1.63M | Buy |
7,401
+97
| +1% | +$21.6K | 0.08% | 99 |
|
|
2023
Q2 | $1.55M | Sell |
7,304
-480
| -6% | -$102K | 0.08% | 100 |
|
|
2023
Q1 | $1.74M | Sell |
7,784
-224
| -3% | -$51K | 0.09% | 95 |
|
|
2022
Q4 | $1.88M | Buy |
8,008
+215
| +3% | +$49.8K | 0.1% | 91 |
|
|
2022
Q3 | $1.79M | Buy |
7,793
+186
| +2% | +$45.5K | 0.09% | 89 |
|
|
2022
Q2 | $1.71M | Sell |
7,607
-143
| -2% | -$32.9K | 0.08% | 89 |
|
|
2022
Q1 | $2.01M | Sell |
7,750
-232
| -3% | -$58.1K | 0.11% | 87 |
|
|
2021
Q4 | $2.33M | Buy |
7,982
+25
| +0.3% | +$6.89K | 0.12% | 82 |
|
|
2021
Q3 | $2.15M | Sell |
7,957
-124
| -2% | -$33.8K | 0.13% | 73 |
|
|
2021
Q2 | $1.92M | Sell |
8,081
-97
| -1% | -$21.5K | 0.11% | 75 |
|
|
2021
Q1 | $1.63M | Sell |
8,178
-206
| -2% | -$41.8K | 0.1% | 74 |
|
|
2020
Q4 | $1.65M | Sell |
8,384
-667
| -7% | -$134K | 0.11% | 75 |
|
|
2020
Q3 | $1.73M | Sell |
9,051
-431
| -5% | -$76.7K | 0.14% | 71 |
|
|
2020
Q2 | $1.48M | Sell |
9,482
-647
| -6% | -$92.9K | 0.14% | 64 |
|
|
2020
Q1 | $1.24M | Sell |
10,129
-2,382
| -19% | -$321K | 0.12% | 67 |
|
|
2019
Q4 | $1.7M | Sell |
12,511
-885
| -7% | -$112K | 0.16% | 63 |
|
|
2019
Q3 | $1.72M | Sell |
13,396
-878
| -6% | -$110K | 0.15% | 77 |
|
|
2019
Q2 | $1.81M | Sell |
14,274
-1,286
| -8% | -$152K | 0.15% | 79 |
|
|
2019
Q1 | $1.82M | Sell |
15,560
-1,889
| -11% | -$194K | 0.15% | 82 |
|
|
2018
Q4 | $1.59M | Sell |
17,449
-2,508
| -13% | -$228K | 0.12% | 86 |
|
|
2018
Q3 | $1.92M | Sell |
19,957
-1,931
| -9% | -$176K | 0.16% | 83 |
|
|
2018
Q2 | $1.92M | Sell |
21,888
-1,089
| -5% | -$97K | 0.16% | 82 |
|
|
2018
Q1 | $1.99M | Buy |
22,977
+19,866
| +639% | +$1.74M | 0.17% | 76 |
|
|
2017
Q4 | $256K | Sell |
3,111
-24,145
| -89% | -$1.96M | 0.08% | 70 |
|
|
2017
Q3 | $2.07M | Sell |
27,256
-3,873
| -12% | -$287K | 0.17% | 74 |
|
|
2017
Q2 | $2.33M | Sell |
31,129
-3,795
| -11% | -$284K | 0.2% | 72 |
|
|
2017
Q1 | $2.65M | Sell |
34,924
-1,488
| -4% | -$111K | 0.23% | 71 |
|
|
2016
Q4 | $2.51M | Sell |
36,412
-1,049
| -3% | -$72.8K | 0.23% | 65 |
|
|
2016
Q3 | $2.6M | Sell |
37,461
-16,336
| -30% | -$1.16M | 0.26% | 56 |
|
|
2016
Q2 | $3.11M | Buy |
53,797
+850
| +2% | +$55.6K | 0.29% | 60 |
|
|
2016
Q1 | $3.38M | Buy |
+52,947
| New | +$3.16M | 0.32% | 50 |
|
Other funds holding DHR
VCM
VPM
Aspiriant LLC's DHR Position: Q1 2026 in Review
Aspiriant LLC reduced its Danaher (DHR) stake by 9.2% in Q1 2026, selling an estimated $88.4K and leaving 4,080 shares worth $774K. The position accounts for 0.02% of the portfolio, ranked #176.
Aspiriant LLC first reported a position in DHR in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.38M in Q1 2016. 2,165 funds tracked by Wall St. Rank hold DHR as of Q1 2026.
- Aspiriant LLC held 4,080 shares of Danaher worth $774K as of Q1 2026.
- Aspiriant LLC sold 415 Danaher shares in Q1 2026, an estimated $88.4K.
- Danaher made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #176 holding.
- Aspiriant LLC first reported a position in Danaher in Q1 2016 and has held it in 41 quarters since.
- Aspiriant LLC's Danaher position peaked at $3.38M in Q1 2016.
- 2,165 funds tracked by Wall St. Rank held Danaher as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.